Deferred Tax Assets, Gross of Vistagen Therapeutics, Inc. from 31 Mar 2012 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: Vistagen Therapeutics, Inc. quarterly Deferred Tax Assets, Gross in USD history and change rate from 31 Mar 2012 to 31 Mar 2025.
Vistagen Therapeutics, Inc. Deferred Tax Assets, Gross for the quarter ending 31 Mar 2025 was $77,705,000, a 28% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Gross, Quarterly (USD)

Deferred Tax Assets, Gross, YoY Quarterly Change (%)

Vistagen Therapeutics, Inc. Quarterly Deferred Tax Assets, Gross (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$77,705,000	+$17,164,000	+28%	31 Mar 2025	10-K	17 Jun 2025	2025	FY
Q1 2024	$60,541,000	+$1,285,000	+2.2%	31 Mar 2024	10-K	17 Jun 2025	2025	FY
Q1 2023	$59,256,000	+$10,635,700	+22%	31 Mar 2023	10-K	11 Jun 2024	2024	FY
Q1 2022	$48,620,300	+$8,743,700	+22%	31 Mar 2022	10-K	28 Jun 2023	2023	FY
Q1 2021	$39,876,600	+$2,921,800	+7.9%	31 Mar 2021	10-K	23 Jun 2022	2022	FY
Q1 2020	$36,954,800	+$4,202,500	+13%	31 Mar 2020	10-K	29 Jun 2021	2021	FY
Q1 2019	$32,752,300	+$7,499,900	+30%	31 Mar 2019	10-K	29 Jun 2020	2020	FY
Q1 2018	$25,252,400	-$9,529,300	-27%	31 Mar 2018	10-K	25 Jun 2019	2019	FY
Q1 2017	$34,781,700	+$3,566,700	+11%	31 Mar 2017	10-K	26 Jun 2018	2018	FY
Q1 2016	$31,215,000	+$31,189,228		31 Mar 2016	10-K	29 Jun 2017	2017	FY
Q1 2015	$25,772^*	+$4,619		31 Mar 2015	10-K	24 Jun 2016	2016	FY
Q1 2014	$21,153^*	+$2,126		31 Mar 2014	10-K	29 Jun 2015	2015	FY
Q1 2013	$19,027^*	+$2,814		31 Mar 2013	10-K	25 Jun 2014	2014	FY
Q1 2012	$16,213^*			31 Mar 2012	10-K	18 Jul 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.